Altered cortical synaptic plasticity in response to 5-Hz repetitive transcranial magnetic stimulation as a new electrophysiological finding in amnestic mild cognitive impairment converting to Alzheimer's disease: Results from a 4-year prospective cohort study

Frontiers in Aging Neuroscience

Volumn 7, Issue JAN, 2016, Pages

  Trebbastoni, Alessandro ^a   Pichiorri, Floriana ^a,b   D'Antonio, Fabrizia ^a   Campanelli, Alessandra ^a   Onesti, Emanuela ^a   Ceccanti, Marco ^a   de Lena, Carlo ^a   Inghilleri, Maurizio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Alzheimer's disease; Cortical excitability; Mild cognitive impairment; N methyl d aspartate acid receptor; Synaptic plasticity; Transcranial magnetic stimulation

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROPSYCHOLOGICAL TEST; PRIMARY MOTOR CORTEX; PROSPECTIVE STUDY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84960131831     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00253     Document Type: Article

References (88)

1. Alagona, G., Bella, R., Ferri, R., Carnemolla, A., Pappalardo, A., Costanzo, E., et al. (2001). Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci. Lett. 314, 57-60. doi: 10.1016/S0304-3940(01)02288-1.
2. Alberici, A., Bonato, C., Calabria, M., Agosti, C., Zanetti, O., Miniussi, C., et al. (2008). The contribution of TMS to frontotemporal dementia variants. Acta Neurol. Scand. 118, 275-280. doi:10.1111/j.1600-0404.2008.01017.x.
3. Appollonio, I., Leone, M., Isella, V., Piamarta, F., Consoli, T., and Villa, M. L. (2005). The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol. Sci. 26, 108-116. doi:10.1007/s10072-005-0443-4.
4. Arevalo-Rodriguez, I., Smailagic, N., Roqué, I., Figuls, M., Ciapponi, A., Sanchez-Perez, E., et al. (2015). Mini-mental state examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst. Rev. 3, CD010783. doi:10.1002/14651858.CD010783.pub2.
5. Barker, A. T., Jalinous, R., and Freeston, I. L. (1985). Non-invasive magnetic stimulation of human motor cortex. Lancet 1, 1106-1107. doi:10.1016/S0140-6736(85)92413-4.
6. Basso, A., Capitani, E., and Laiacona, M. (1987). Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct. Neurol. 2, 189-194.
7. Baudry, M., and Lynch, G. (2001). Remembrance of arguments past: how well is the glutamate receptor hypothesis of LTP holding up after 20 years? Neurobiol. Learn. Mem. 76, 284-297. doi:10.1006/nlme.2001.4023.
8. Bell, K. F., Bennett, D. A., and Cuello, A. C. (2007). Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J. Neurosci. 27, 10810-10817. doi:10.1523/JNEUROSCI.3269-07.2007.
9. Bennett, D. A. (2003). Update on mild cognitive impairment. Curr. Neurol. Neurosci. Rep. 3, 379-384. doi:10.1007/s11910-003-0020-2.
10. Berardelli, A., Inghilleri, M., Rothwell, J. C., Romeo, S., Currà, A., Gilio, F., et al. (1998). Facilitation of muscle evoked responses after repetitive cortical stimulation in man. Exp. Brain Res. 122, 79-84. doi:10.1007/s002210050493.
11. Braak, H., Braak, E., Bohl, J., and Bratzke, H. (1998). Evolution of Alzheimer's disease related cortical lesions. J. Neural. Transm. Suppl. 54, 97-106. doi:10.1007/978-3-7091-7508-8_9.
12. Caffarra, P., Gardini, S., Zonato, F., Concari, L., Dieci, F., and Copelli, S. (2011). Italian norms for the Freedman version of the clock drawing test. J. Clin. Exp. Neuropsychol. 33, 982-988. doi:10.1080/13803395.2011.589373.
13. Caffarra, P., Vezzadini, G., Dieci, F., Zonato, F., and Venneri, A. (2002). Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol. Sci. 22, 443-447. doi:10.1007/s100720200003.
14. Carlesimo, G. A., Caltagirone, C., and Gainotti, G. (1996). The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur. Neurol. 36, 378-384. doi:10.1159/000117297.
15. Castro-Alamancos, M. A., and Connors, B. W. (1996). Short-term synaptic enhancement and long-term potentiation in neocortex. Proc. Natl. Acad. Sci. U.S.A. 93, 1335-1339. doi:10.1073/pnas.93.3.1335.
16. Danysz, W., and Parsons, C. G. (2012). Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine-searching for the connections. Br. J. Pharmacol. 167, 324-352. doi:10.1111/j.1476-5381.2012.02057.x.
17. de Carvalho, M., de Mendonça, A., Miranda, P. C., Garcia, C., and Luís, M. L. (1997). Magnetic stimulation in Alzheimer's disease. J. Neurol. 244, 304-307. doi:10.1007/s004150050091.
18. Di Lazzaro, V., Oliviero, A., Pilato, F., Saturno, E., Dileone, M., Marra, C., et al. (2004). Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 75, 555-559. doi:10.1136/jnnp.2003.018127.
19. Di Lazzaro, V., Oliviero, A., Pilato, F., Saturno, E., Dileone, M., and Tonali, P. A. (2003a). Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: evidence of impaired glutamatergic neurotransmission? Ann. Neurol. 53, 824. doi:10.1002/ana.10600.
20. Di Lazzaro, V., Oliviero, A., Profice, P., Pennisi, M. A., Pilato, F., Zito, G., et al. (2003b). Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J. Physiol. 547, 485-496. doi:10.1113/jphysiol.2002.030486.
21. Di Lazzaro, V., Oliviero, A., Tonali, P. A., Marra, C., Daniele, A., Profice, P., et al. (2002). Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 59, 392-397. doi:10.1212/WNL.59.3.392.
22. Di Lazzaro, V., Pilato, F., Dileone, M., Saturno, E., Oliviero, A., Marra, C., et al. (2006). In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66, 1111-1113. doi:10.1212/01.wnl.0000204183.26231.23.
23. Drago, V., Babiloni, C., Bartrés-Faz, D., Caroli, A., Bosch, B., Hensch, T., et al. (2011). Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. J. Alzheimers Dis. 26(Suppl. 3), 159-199. doi:10.3233/JAD-2011-0043.
24. Ebly, E. M., Hogan, D. B., and Parhad, I. M. (1995). Cognitive impairment in the nondemented elderly. Results from the Canadian study of health and aging. Arch. Neurol. 52, 612-619. doi:10.1001/archneur.1995.00540300086018.
25. Espinosa, A., Alegret, M., Valero, S., Vinyes-Junqué, G., Hernández, I., Mauleón, A., et al. (2013). A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J. Alzheimers Dis. 34, 769-780. doi:10.3233/JAD-122002.
26. Farias, S. T., Mungas, D., Reed, B. R., Harvey, D., and DeCarli, C. (2009). Progression of mild cognitive impairment to dementia in clinic-vs community-based cohorts. Arch. Neurol. 66, 1151-1157. doi:10.1001/archneurol.2009.106.
27. Farlow, M. R. (2004). NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics 59, 22-27.
28. Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., and Zimmerman, R. A. (1987). MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol. 149, 351-356. doi:10.2214/ajr.149.2.351.
29. Ferreri, F., Pauri, F., Pasqualetti, P., Fini, R., Dal Forno, G., and Rossini, P. M. (2003). Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann. Neurol. 53, 102-108. doi:10.1002/ana.10416.
30. Flicker, C., Ferris, S. H., and Reisberg, B. (1991). Mild cognitive impairment in the elderly: predictors of dementia. Neurology 41, 1006-1009. doi:10.1212/WNL.41.7.1006.
31. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198. doi:10.1016/0022-3956(75)90026-6.
32. Geslani, D., Tierney, M. C., Herrmann, N., and Szalai, J. (2005). Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 19, 383-389. doi:10.1159/000084709.
33. Giovagnoli, A. R., Del Pesce, M., Mascheroni, S., Simoncelli, M., Laiacona, M., and Capitani, E. (1996). Trail making test: normative values from 287 normal adult controls. Ital. J. Neurol. Sci. 17, 305-309. doi:10.1007/BF01997792.
34. Hampel, H., Bürger, K., Teipel, S. J., Bokde, A. L., Zetterberg, H., and Blennow, K. (2008). Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 4, 38-48. doi:10.1016/j.jalz.2007.08.006.
35. Hanson, J. E., Pare, J. F., Deng, L., Smith, Y., and Zhou, Q. (2015). Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease. Neurobiol. Dis. 74, 254-262. doi:10.1016/j.nbd.2014.11.017.
36. Höffken, O., Haussleiter, I. S., Westermann, A., Lötsch, J., Maier, C., Tegenthoff, M., et al. (2013). Influence of (S)-ketamine on human motor cortex excitability. Exp. Brain Res. 225, 47-53. doi:10.1007/s00221-012-3347-6.
37. Hoogendam, J. M., Ramakers, G. M., and Di Lazzaro, V. (2010). Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul. 3, 95-118. doi:10.1016/j.brs.2009.10.005.
38. Inghilleri, M., Conte, A., Frasca, V., Curra', A., Gilio, F., Manfredi, M., et al. (2004). Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation. Exp. Brain Res. 154, 488-493. doi:10.1007/s00221-003-1685-0.
39. Inghilleri, M., Conte, A., Frasca, V., Gilio, F., Lorenzano, C., and Berardelli, A. (2005). Synaptic potentiation induced by rTMS. Effect of lidocaine infusion. Exp. Brain Res. 163, 114-117. doi:10.1007/s00221-005-2225-x.
40. Inghilleri, M., Conte, A., Frasca, V., Scaldaferri, N., Gilio, F., Santini, M., et al. (2006). Altered response to rTMS in patients with Alzheimer's disease. Clin. Neurophysiol. 117, 103-109. doi:10.1016/j.clinph.2005.09.016.
41. Jennum, P., Winkel, H., and Fuglsang-Frederiksen, A. (1995). Repetitive magnetic stimulation and motor evoked potentials. Electroencephalogr. Clin. Neurophysiol. 97, 96-101. doi:10.1016/0924-980X(94)00293-G.
42. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., et al. (2003). APP processing and synaptic function. Neuron 37, 925-937. doi:10.1016/S0896-6273(03)00124-7.
43. Kobayashi, M., and Pascual-Leone, A. (2003). Transcranial magnetic stimulation in neurology. Lancet Neurol. 2, 145-156. doi:10.1016/S1474-4422(03)00321-1.
44. Kral, V. A. (1962). Senescent forgetfulness: benign and malignant. Can. Med. Assoc. J. 86, 257-260.
45. Lawton, M. P., and Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186. doi:10.1093/geront/9.3_Part_1.179.
46. Levy, R. (1994). Aging-associated cognitive decline. Working party of the international psychogeriatric association in collaboration with the world health organization. Int. Psychogeriatr. 6, 63-68. doi:10.1017/S1041610294001626.
47. Malenka, R. C., and Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron 44, 5-21. doi:10.1016/j.neuron.2004.09.012.
48. Martin, S. J., Grimwood, P. D., and Morris, R. G. (2000). Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649-711. doi:10.1146/annurev.neuro.23.1.649.
49. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944. doi:10.1212/WNL.34.7.939.
50. Mitchell, A. J., and Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252-265. doi:10.1111/j.1600-0447.2008.01326.x.
51. Modugno, N., Nakamura, Y., MacKinnon, C. D., Filipovic, S. R., Bestmann, S., Berardelli, A., et al. (2001). Motor cortex excitability following short trains of repetitive magnetic stimuli. Exp. Brain Res. 140, 453-459. doi:10.1007/s002210100843.
52. Moodley, K. K., and Chan, D. (2014). The hippocampus in neurodegenerative disease. Front. Neurol. Neurosci. 34:95-108. doi:10.1159/000356430.
53. Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. doi:10.1212/WNL.43.11.2412-a.
54. Mota, S. I., Ferreira, I. L., and Rego, A. C. (2014). Dysfunctional synapse in Alzheimer's disease-a focus on NMDA receptors. Neuropharmacology 76 Pt A, 16-26. doi:10.1016/j.neuropharm.2013.08.013.
55. Nardone, R., Bergmann, J., Christova, M., Caleri, F., Tezzon, F., Ladurner, G., et al. (2012). Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J. Neural Transm. 119, 463-471. doi:10.1007/s00702-011-0725-3.
56. Nardone, R., Bergmann, J., Kronbichler, M., Kunz, A., Klein, S., Caleri, F., et al. (2008). Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J. Neural Transm. 115, 1557-1562. doi:10.1007/s00702-008-0129-1.
57. Nardone, R., Bratti, A., and Tezzon, F. (2006). Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. J. Neural Transm. 113, 1679-1684. doi:10.1007/s00702-006-0551-1.
58. Nardone, R., Tezzon, F., Höller, Y., Golaszewski, S., Trinka, E., and Brigo, F. (2014). Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease. Acta Neurol. Scand. 129, 351-366. doi:10.1111/ane.12223.
59. Neves, G., Cooke, S. F., and Bliss, T. V. (2008). Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9, 65-75. doi:10.1038/nrn2303.
60. Niskanen, E., Könönen, M., Määttä, S., Hallikainen, M., Kivipelto, M., Casarotto, S., et al. (2011). New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. PLoS ONE 6:e26113. doi:10.1371/journal.pone.0026113.
61. Novelli, G., Papagno, C., Capitani, E., Laiacona, M., Cappa, S. F., and Vallar, G. (1996). Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch. Psicol. Neurol. Psichiatr. 47, 477-506.
62. Orsini, A., Grossi, D., Capitani, E., Laiacona, M., Papagno, C., and Vallar, G. (1987). Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital. J. Neurol. Sci. 8, 539-548. doi:10.1007/BF02333660.
63. Pascual-Leone, A., Tormos, J. M., Keenan, J., Tarazona, F., Cañete, C., and Catalá, M. D. (1998). Study and modulation of human cortical excitability with transcranial magnetic stimulation. J. Clin. Neurophysiol. 15, 333-343. doi:10.1097/00004691-199807000-00005.
64. Pascual-Leone, A., Valls-Sollè, J., Wasserman, E. M., and Hallett, M. (1994). Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117, 847-858. doi:10.1093/brain/117.4.847.
65. Pennisi, G., Alagona, G., Ferri, R., Greco, S., Santonocito, D., Pappalardo, A., et al. (2002). Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci. Lett. 329, 293-296. doi:10.1016/S0304-3940(02)00701-2.
66. Pennisi, G., Ferri, R., Lanza, G., Cantone, M., Pennisi, M., Puglisi, V., et al. (2011). Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability. J. Neural Transm. 118, 587-598. doi:10.1007/s00702-010-0554-9.
67. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183-194. doi:10.1111/j.1365-2796.2004.01388.x.
68. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303-308. doi:10.1001/archneur.56.3.303.
69. Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., et al. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352, 2379-2388. doi:10.1056/NEJMoa050151.
70. Reisberg, B., Ferris, S. H., de Leon, M. J., and Crook, T. (1982). The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139, 1136-1139. doi:10.1176/ajp.139.9.1136.
71. Ridding, M. C., and Ziemann, U. (2010). Determinants of the induction of cortical plasticity by non-invasive brain stimulation in healthy subjects. J. Physiol. 588(Pt 13), 2291-2304. doi:10.1113/jphysiol.2010.190314.
72. Romeo, S., Gilio, F., Pedace, F., Ozkaynak, S., Inghilleri, M., and Manfredi, M. (2000). Changes in the cortical silent period after repetitive magnetic stimulation of cortical motor areas. Exp. Brain Res. 135, 504-510. doi:10.1007/s002210000541.
73. Rossi, S., Hallett, M., Rossini, P. M., and Pascual-Leone, A. (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120, 2008-2039. doi:10.1016/j.clinph.2009.08.016.
74. Sakuma, K., Murakami, T., and Nakashima, K. (2007). Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin. Neurophysiol. 118, 1460-1463. doi:10.1016/j.clinph.2007.03.018.
75. Schaeffer, E. L., and Gattaz, W. F. (2008). Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl.) 198, 1-27. doi:10.1007/s00213-008-1092-0.
76. Scheuer, K., Maras, A., Gattaz, W. F., Cairns, N., Förstl, H., and Müller, W. E. (1996). Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7, 210-214.
77. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., and Smith, I. (2008). Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842. doi:10.1038/nm1782.
78. Spinnler, H., and Tognoni, G. (1987). Standardizzazione e taratura italiana di test neuropsicologici. Ital. J. Neurol. Sci. (Suppl. 8), 1-20.
79. Terranova, C., SantAngelo, A., Morgante, F., Rizzo, V., Allegra, R., Arena, M. G., et al. (2013). Impairment of sensory-motor plasticity in mild Alzheimer's disease. Brain Stimul. 6, 62-66. doi:10.1016/j.brs.2012.01.010.
80. Tokuchi, R., Hishikawa, N., Kurata, T., Sato, K., Kono, S., Yamashita, T., et al. (2014). Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. J. Neurol. Sci. 346, 288-292. doi:10.1016/j.jns.2014.09.012.
81. Trebbastoni, A., Gilio, F., D'Antonio, F., Cambieri, C., Ceccanti, M., de Lena, C., et al. (2012). Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation. Clin. Neurophysiol. 123, 902-909. doi:10.1016/j.clinph.2011.09.010.
82. Vallence, A. M., and Ridding, M. C. (2014). Non-invasive induction of plasticity in the human cortex: uses and limitations. Cortex 58, 261-271. doi:10.1016/j.cortex.2013.12.006.
83. Van Gorp, W. G., Satz, P., Kiersch, M. E., and Henry, R. (1986). Normative data on the Boston naming test for a group of normal older adults. J. Clin. Exp. Neuropsychol. 8, 702-705. doi:10.1080/01688638608405189.
84. van Marwijk, H. W., Wallace, P., de Bock, G. H., Hermans, J., Kaptein, A. A., and Mulder, J. D. (1995). Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br. J. Gen. Pract. 45, 195-199.
85. van Rossum, I. A., Vos, S., Handels, R., and Visser, P. J. (2010). Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. J. Alzheimers Dis. 20, 881-891. doi:10.3233/JAD-2010-091606.
86. Varga, E., Juhász, G., Bozsó, Z., Penke, B., Fülöp, L., and Szegedi, V. (2015). Amyloid-ß1-42 disrupts synaptic plasticity by altering glutamate recycling at the synapse. J. Alzheimers Dis. 45, 449-456. doi:10.3233/JAD-142367.
87. Walsh, D. M., and Selkoe, D. J. (2004). Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193. doi:10.1016/j.neuron.2004.09.010.
88. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J. Intern. Med. 256, 240-246. doi:10.1111/j.1365-2796.2004.01380.x.